The Ischemic And Hemorrhagic Update would like to thank all of our partners and exhibitors for participating with the Annual course.
Alexion, Allergan, Balt, Encompass Health, Genentech, Medtronic, Microvention, Northeast Rehabilitation Hospital, Penumbra and Stryker
Enjoy the break & The Virtual exhibits below
Intended for US audience only
Alexion is a global biopharmaceutical company with the mission of helping the lives of people affected by rare diseases by continuously innovating and creating meaningful value in all that we do. Headquartered in Boston, Massachusetts, ALexion has office around the globe and serves patients in more than 50 countries
US/POR – ADX/1455
Allergan an AbbVie Company is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
A text blurb with 100 characters: Balt is a global leader in the innovation of novel products for the interventional access and treatment of neurovascular diseases. Balt products are used around the world to access and treat multiple disease states including arterial venous malformations, aneurysms, and ischemic stroke.
Encompass Health is the largest provider of acute inpatient rehabilitation with nine hospital locations in New England. We provide a higher level of care to patients recovering from stroke, brain and spinal cord injury, and other neurological disorders, amputations, orthopedic, cardiac, pulmonary and other medical conditions. Additionally, our experienced inpatient rehabilitation team designs programs that meet the personalized needs of each patient, reaching goals of independence for a better way of life.
Encompass Health of New England
Encompass Health of Braintree
We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary.
MicroVention provides a complete approach to neuroendovascular technologies with 4 main product groups: Aneurysm Therapy Solutions, Ischemic Stroke & Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products.
Our Stroke and Brain Injury Recovery Programs are TJC accredited and have earned disease-specific care certification. Patients receive daily access to medical management and rehabilitation services from dedicated hospitalists, physiatrists, RNs, therapists and specialty physicians plus at least 3 hours of therapy 5 days/week including PT, OT, speech.
Penumbra, Inc. is a global healthcare company focused on innovative therapies that address challenging medical conditions & unmet needs
Rapid Medical develops premier, responsive interventional devices for neurovascular diseases such as ischemic and hemorrhagic stroke. Utilizing novel manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the intravascular environment, expanding operative capabilities and increasing control over procedural outcomes. TIGERTRIEVER™17 and 21, COMANECI™ and COLUMBUS™/DRIVEWIRE are CE marked and FDA cleared. TIGERTRIEVER™13 and XL are also CE marked. For more information, visit www.rapid-medical.com, or contact your local Rapid Medical Territory Manager.
Stryker Neurovascular is committed to Complete Stroke Care through innovative products, technologies and services for ischemic and hemorrhagic stroke. By advancing the practice of less-invasive medicine, providing healthcare professionals more endovascular solutions and promoting clinical education and support, Stryker Neurovascular is dedicated to helping deliver better patient outcomes.